News

FFAR Funds Veterinary Research to Address Pandemic Diseases

In response to the coronavirus pandemic, the Foundation for Food and Agriculture Research (FFAR) is funding five additional Vet Fellowships to conduct pandemic and zoonotic research. The FFAR Vet Fellows program equips veterinary students with the expertise to address future agricultural challenges.

Up to 75 percent of emerging infectious diseases are zoonotic, meaning a pathogen can spread from animals to humans. Both coronaviruses and influenza viruses can be zoonotic and can be found in agricultural animals such as poultry and pigs. Research on food-animal production and veterinary medicine can reduce the threat of zoonotic pathogens. Yet, veterinary students have limited opportunities to research zoonotic diseases in agriculture.

“The coronavirus is an example of how pathogens can move between humans and animals,” said FFAR’s Executive Director Sally Rockey. “Understanding new diseases in animals, and especially how they spread, is vital to slowing transmission and developing remedies. FFAR is expanding the Vet Fellows to assure we have the expertise in the veterinary community to address what could be future pandemics.”

A recent JAVMA article agrees that veterinarians are needed in the research field to be part of the solution. FFAR is ensuring that the future scientific workforce includes veterinarians with expertise in zoonotic pathogens by funding five additional Vet Fellowships to conduct research on pathogens that threaten agricultural productivity and human health. To bolster the scientific workforce in response to the coronavirus, FFAR is not requiring the 2020 Vet Fellows to secure matching funds. Additionally, FFAR and the Association of American Veterinary Medical Colleges (AAVMC), who partners with FFAR to administer the program, extended the nomination deadline to May 6, 2020.

The FFAR Vet Fellows program will still support ten students to conduct research on agricultural productivity, public health and environmental sustainability. Information about applying for the FFAR Vet Fellows Program is available on FFAR’s website. The fifteen 2020 FFAR Vet Fellows will be announced in summer 2020.

Recent News

03/19/2026

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced a new genetic testing program with Zevra Therapeutics, Inc. (Nasdaq: ZVRA), a commercial-stage biopharmaceutical company focused on bringing life-changing therapeutics to people living with rare diseases. The Niemann-Pick Disease type C (NPC) Sponsored Genetic Testing

03/18/2026

Phlow Corp. Appoints Dawn Von Rohr as Chief Operating Officer to Advance Domestic Pharmaceutical Manufacturing

Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dawn Von Rohr has been appointed Chief Operating Officer (COO). Von Rohr will oversee Phlow’s operations, manufacturing execution, and strategic growth initiatives as the company continues expanding its advanced pharmaceutical development and manufacturing infrastructure in the United States to

03/17/2026

W&M Undergrads expand the chemical toolbox for cancer drugs

Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from unwanted side effects and limited efficacy. In a recent Bioconjugate Chemistry publication, William & Mary researchers designed an antibody-drug conjugate (ADC) with the potential to improve the potency and decrease the cost of currently approved cancer drugs. Like